Can family therapy prevent psychosis in At-Risk youth?

NCT ID NCT04338152

Ongoing Disease control Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a family-focused therapy for 220 youth aged 13-25 who show early signs of psychosis risk. The therapy aims to reduce symptoms and prevent the development of full psychosis over 18 months. Participants receive either the family therapy or a comparison treatment, with regular check-ins to track progress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Prodromal Symptoms Psychotic Disorders schizotypal personality disorder psychotic disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FAMILY PRODROMAL SCHIZOPHRENIA PRODROMAL SYMPTOMS PSYCHOSIS PSYCHOTIC DISORDERS

Contacts and locations

Locations

Harvard University/Beth Israel Deconess Medical Center

Boston, Massachusetts, 02215, United States
University of Calgary

Calgary, Alberta, Canada
University of California, Los Angeles

Los Angeles, California, 90095, United States
University of California, San Diego

San Diego, California, 92093, United States
University of California, San Francisco School of Medicine

San Francisco, California, 94121, United States
Yale University

New Haven, Connecticut, 06519, United States
Zucker Hillside Hospital

New York, New York, 11004, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.